194 related articles for article (PubMed ID: 28502488)
1. Lipoprotein-associated phospholipase A2 and its relationship with markers of subclinical cardiovascular disease: A systematic review.
Younus A; Humayun C; Ahmad R; Ogunmoroti O; Kandimalla Y; Aziz M; Malik R; Saand AR; Valdes C; Badlani R; Younus MA; Ali SS; Chen Y; Nasir K
J Clin Lipidol; 2017; 11(2):328-337. PubMed ID: 28502488
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein-associated phospholipase A
Öngen B; Kalkan Uçar S; Levent E; Azarsız E; Koloğlu T; Çoker M; Sözmen E; Sağın FG
Ann Clin Biochem; 2017 Sep; 54(5):539-547. PubMed ID: 27614353
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.
Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA
HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker.
Vittos O; Toana B; Vittos A; Moldoveanu E
Biomarkers; 2012 Jun; 17(4):289-302. PubMed ID: 22401038
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.
Mangili A; Ahmad R; Wolfert RL; Kuvin J; Polak JF; Karas RH; Wanke CA
Clin Infect Dis; 2014 Mar; 58(6):893-900. PubMed ID: 24336757
[TBL] [Abstract][Full Text] [Related]
9. Association between the lipoprotein-associated phospholipase A2 activity and the progression of subclinical atherosclerosis.
Liu J; Wang W; Qi Y; Yong Q; Zhou G; Wang M; Sun J; Liu J; Jia Z; Zhao D
J Atheroscler Thromb; 2014; 21(6):532-42. PubMed ID: 24492522
[TBL] [Abstract][Full Text] [Related]
10. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.
Ragab SM; Safan MA; Obeid OM; Sherief AS
Hematology; 2015 May; 20(4):228-38. PubMed ID: 25056687
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein-associated phospholipase A2: how effective as a risk marker of cardiovascular disease and as a therapeutic target?
Ahmed MS; Ji JZ; Meng QH
Inflamm Allergy Drug Targets; 2011 Aug; 10(4):236-46. PubMed ID: 21539512
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholine and carotid intima-media thickness in young smokers: a role for oxidized LDL-induced expression of PBMC lipoprotein-associated phospholipase A2?
Fratta Pasini A; Stranieri C; Pasini A; Vallerio P; Mozzini C; Solani E; Cominacini M; Cominacini L; Garbin U
PLoS One; 2013; 8(12):e83092. PubMed ID: 24358251
[TBL] [Abstract][Full Text] [Related]
14. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review.
Garza CA; Montori VM; McConnell JP; Somers VK; Kullo IJ; Lopez-Jimenez F
Mayo Clin Proc; 2007 Feb; 82(2):159-65. PubMed ID: 17290721
[TBL] [Abstract][Full Text] [Related]
15. Analysis of intima-media thickness of carotid artery and lipoprotein-associated phospholipase A2 in coronary heart diseases of different types.
Li Y
Technol Health Care; 2015; 23 Suppl 1():S147-50. PubMed ID: 26410317
[TBL] [Abstract][Full Text] [Related]
16. Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction.
Yang Y; Xue T; Zhu J; Xu J; Hu X; Wang P; Kong T; Yan Y; Yang L; Xue S
Clin Neurol Neurosurg; 2017 Sep; 160():40-45. PubMed ID: 28644968
[TBL] [Abstract][Full Text] [Related]
17. Lp-PLA2, scavenger receptor class B type I gene (SCARB1) rs10846744 variant, and cardiovascular disease.
Manichaikul A; Wang XQ; Li L; Erdmann J; Lettre G; Bis JC; Waterworth D; Cushman M; Jenny NS; Post WS; Palmas W; Tsai MY; Wallentin L; White H; Schunkert H; O'Donnell CJ; Herrington DM; Rich SS; O'Donoghue ML; Rodriguez A
PLoS One; 2018; 13(10):e0204352. PubMed ID: 30289950
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2.
McConnell JP; Hoefner DM
Clin Lab Med; 2006 Sep; 26(3):679-97, vii. PubMed ID: 16938590
[TBL] [Abstract][Full Text] [Related]
19. The Utility of the Lipoprotein-Associated Phospholipase A
Mayne ES; Moabi H; Grobbee DE; Barth RE; Klipstein-Grobusch K; Stevens WS; Vos AG; Louw S
Clin Appl Thromb Hemost; 2019; 25():1076029619883944. PubMed ID: 31686546
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-associated phospholipase A2 in coronary heart disease: Review and meta-analysis.
Li D; Zhao L; Yu J; Zhang W; Du R; Liu X; Liu Y; Chen Y; Zeng R; Cao Y; Zeng Z; Zhao Z; Wu J
Clin Chim Acta; 2017 Feb; 465():22-29. PubMed ID: 27956130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
